Downloaded on 6/23/2024 17:44:53

2023 Journal Performance Data for:

PHARMACIA
Open Access since 2007

ISSN EISSN
0428-0296 2603-557X

JCR ABBREVIATION ISO ABBREVIATION

PHARMACIA Pharmacia

Journal Information
EDITION CATEGORY
Emerging Sources Citation PHARMACOLOGY &
Index (ESCI) PHARMACY - undefined

LANGUAGES REGION 1ST ELECTRONIC JCR YEAR

English BULGARIA 2020

Publisher Information
PUBLISHER ADDRESS PUBLICATION FREQUENCY
PENSOFT PUBLISHERS 12 PROF GEORGI ZLATARSKI 4 issues/year
ST, SOFIA 1700, BULGARIA

Journal Citation Reports ™ 1-23 © 2024 Clarivate

Journal's Performance

Journal Impact Factor

The Journal Impact Factor (JIF) is a journal-level metric calculated from data indexed in the Web of
Science Core Collection. It should be used with careful attention to the many factors that influence
citation rates, such as the volume of publication and citations characteristics of the subject area and
type of journal. The Journal Impact Factor can complement expert opinion and informed peer review.
In the case of academic evaluation for tenure, it is inappropriate to use a journal-level metric as a
proxy measure for individual researchers, institutions, or articles. Learn more

2023 JOURNAL IMPACT FACTOR 2023 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS

1.1 1.0

Journal Impact Factor Trend 2023

Journal Citation Reports ™ 2-23 © 2024 Clarivate

 Journal Impact Factor is calculated using the following metrics

Citations in 2023 to items published in 2021 (155) -

2022 (125) 280
= = 1.1
Number of citable items in 2021 (121) + 2022 (131) 252

Journal Impact Factor without self cites is calculated using the following metrics

Citations in 2023 to items published in 2021 (155) +

2022 (125) - Self Citations in 2023 to items published in
2021 (23) + 2022 (16) 280 - 39
= = 1.0
Number of citable items in 2021 (121) + 2022 (131) 252

Journal Citation Reports ™ 3-23 © 2024 Clarivate

Journal Impact Factor Contributing Items

Citable Items (252)

TITLE CITATION COUNT

Synthesis of new series of pyrimidine nucleoside derivatives bearing the acyl 10

moieties as potential antimicrobial agents
Authors: Bulbul, Md Z. H.;Chowdhury, Tasneem S.;Misbah, Md M. H.;Ferdous,
Jannatul;Dey, Sujan;Hasan, Imtiaj;Fujii, Yuki;Ozekis, Yasuhiro;Kawsar, Sarkar
M. A.
Volume: 68
Accession number: WOS:000607851800004
Document Type: Article

Synthesis and evaluation of inhibitory potentials of microbial biofilms and 8

quorum- sensing by 3-(1,3-dithian-2-ylidene) pentane- 2,4-dione and ethyl-2-
cyano-2-(1,3-dithian-2- ylidene) acetate
Authors: Tamfu, Alfred Ngenge;Boukhedena, Wafia;Boudiba,
Sameh;Deghboudj, Samir;Ceylan, Ozgur
Volume: 69
Accession number: WOS:000906935300005
Document Type: Article

Synthesis, docking study, and structure activity relationship of novel anti- 8

tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic
acid) moiety
Authors: Alsaad, Hiba;Kubba, Ammar;Tahtamouni, Lubna H.;Hamzah, Ali H.
Volume: 69
Accession number: WOS:000800534500006
Document Type: Article

A novel derivative of picolinic acid induces endoplasmic reticulum stress- 6

mediated apoptosis in human non-small cell lung cancer cells: synthesis,
docking study, and anticancer activity
Authors: Abbas, Ali H.;Mahmood, Ammar A. Razzak;Tahtamouni, Lubna H.;Al-
Mazaydeh, Zainab A.;Rammaha, Majdoleen S.;Alsoubani, Fatima;Al-bayati,
Rheda, I
Volume: 68
Accession number: WOS:000712993200005
Document Type: Article

Analysis of fatty acid composition content in the plant components of 5

antidiabetic herbal mixture by GC-MS
Authors: Savych, Alona;Basaraba, Roksolana;Muzyka, Nataliia;Ilashchuk,
Pavlina
Volume: 68
Accession number: WOS:000653016300003
Document Type: Article

Showing 1-5 rows of 252 total (use export in the relevant section to download the full table)

Journal Citation Reports ™ 4-23 © 2024 Clarivate

Journal Impact Factor Contributing Items

Citing Sources (156)

SOURCE NAME COUNT

PHARMACIA 39

MOLECULES 8

JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH 6

ACS OMEGA 5

FOODS 5

MEDICINAL CHEMISTRY 5

PHARMACEUTICS 5

PLANTS-BASEL 5

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 4

JOURNAL OF CLINICAL MEDICINE 4

PHARMACEUTICALS 4

CHEMISTRYSELECT 3

FARMACIA 3

HELIYON 3

JOURNAL OF CHEMICAL RESEARCH 3

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY 3

JOURNAL OF MOLECULAR STRUCTURE 3

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE 3

LETTERS IN DRUG DESIGN & DISCOVERY 3

MEDICINAL CHEMISTRY RESEARCH 3

Showing 1-20 rows of 156 total (use export in the relevant section to download the full table)

Journal Citation Reports ™ 5-23 © 2024 Clarivate

Journal Citation Indicator (JCI)
0.36
The Journal Citation Indicator (JCI) is the average Category Normalized Citation Impact (CNCI) of
citable items (articles & reviews) published by a journal over a recent three year period. The average
JCI in a category is 1. Journals with a JCI of 1.5 have 50% more citation impact than the average in
that category. It may be used alongside other metrics to help you evaluate journals. Learn more

Journal Citation Reports ™ 6-23 © 2024 Clarivate

Total Citations
445
The total number of times that a journal has been cited by all journals included in the database in the
JCR year. Citations to journals listed in JCR are compiled annually from the JCR years combined
database, regardless of which JCR edition lists the journal.

Journal Citation Reports ™ 7-23 © 2024 Clarivate

Citation Distribution
The Citation Distribution shows the frequency with which items published in the year or two years
prior were cited in the JCR data year (i.e., the component of the calculation of the JIF). The graph has
similar functionality as the JIF Trend graph, including hover-over data descriptions for each data
point, and an interactive legend where each data element's legend can be used as a toggle. You can
view Articles, Reviews, or Non-Citable (other) items to the JIF numerator. Learn more

ARTICLE CITATION MEDIAN REVIEW CITATION MEDIAN UNLINKED CITATIONS

1 1 2

0 times cited
ARTICLES REVIEWS OTHER

105 10 0

Journal Citation Reports ™ 8-23 © 2024 Clarivate

Open Access (OA)

The data included in this tile summarizes the items published in the journal in the JCR data year and
in the previous two years. This three-year set of published items is used to provide descriptive
analysis of the content and community of the journal.Learn more

Items
TOTAL CITABLE % OF CITABLE OA

386 95.08%

CITABLE NON-CITABLE

GOLD OPEN ACCESS OTHER (NON-CITABLE ITEMS)

367 / 95.08% 0 / 0.00%

SUBSCRIPTION OR BRONZE
19 / 4.92%

Citations*
TOTAL CITABLE % OF CITABLE OA

299 95.32%

CITABLE NON-CITABLE

GOLD OPEN ACCESS OTHER (NON-CITABLE ITEMS)

285 / 94.06% 0 / 0.00%

SUBSCRIPTION OR BRONZE UNLINKED CITATIONS

14 / 4.62% 4 / 1.32%

* Citations in 2023 to items published in (2021-2023)

Journal Citation Reports ™ 9-23 © 2024 Clarivate

Rank by Journal Impact factor
Journals within a category are sorted in descending order by Journal Impact Factor (JIF) resulting in
the Category Ranking below. A separate rank is shown for each category in which the journal is listed
in JCR. Beginning in 2023, ranks are calculated by category. Learn more

CATEGORY
PHARMACOLOGY & PHARMACY
296/354
JCR JIF RANK QUART JIF PERCENTILE
YEAR ILE
2023 296/354 Q4 16.5

Journal Citation Reports ™ 10-23 © 2024 Clarivate

Rank by Journal Citation Indicator (JCI)
Journals within a category are sorted in descending order by Journal Citation Indicator (JCI)
resulting in the Category Ranking below. A separate rank is shown for each category in which the
journal is listed in JCR. Data for the most recent year is presented at the top of the list, with other
years shown in reverse chronological order.Learn more

CATEGORY
PHARMACOLOGY & PHARMACY
278/354
JCR JCI RANK QUART JCI PERCENTILE
YEAR ILE
2023 278/354 Q4 21.61
2022 290/366 Q4 20.90
2021 327/361 Q4 9.56
2020 326/357 Q4 8.82
2019 337/353 Q4 4.67
2018 335/343 Q4 2.48
2017 329/336 Q4 2.23

Journal Citation Reports ™ 11-23 © 2024 Clarivate

Citation network
Cited Half-life
2.5 years
The Cited Half-Life is the median age of the items in this journal that were cited in the JCR year. Half
of a journal's cited items were published more recently than the cited half-life.

TOTAL NUMBER OF CITES NON-SELF CITATIONS SELF CITATIONS

445 391 54

# OF CITES FROM CUMULATIVE # OF CITING

2023 % SOURCES

445 citations 100.00% 235 sources

23 citations 5.17% 16 sources

125 citations 33.26% 87 sources
155 citations 68.09% 100 sources
53 citations 80.00% 46 sources
37 citations 88.31% 35 sources
10 citations 90.56% 10 sources
5 citations 91.69% 5 sources
3 citations 92.36% 3 sources
2 citations 92.81% 2 sources
4 citations 93.71% 4 sources

Previous years:
28 citations

Journal Citation Reports ™ 12-23 © 2024 Clarivate

Citing titles in all years
PHARMACIA
SOURCE NAME COUNT

All Others 170

1 PHARMACIA 54

2 MOLECULES 12

3 Plants-Basel 9

4 Foods 8

5 Journal of Pharmacy & Pharmacognosy Research 8

6 Pharmaceutics 7

7 ACS Omega 6

8 ChemistrySelect 6

9 Pharmaceuticals 6

10 Anti-Cancer Agents in Medicinal Chemistry 5

11 BIOORGANIC CHEMISTRY 5

12 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 5

13 Medicinal Chemistry 5

14 FARMACIA 4

15 JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS 4

16 Journal of Clinical Medicine 4

17 JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY 4

18 Journal of Molecular Structure 4

19 Journal of Pharmaceutical Policy and Practice 4

20 Letters in Drug Design & Discovery 4

Showing 1 - 20 rows of 63 total (use export in the relevant section to download the full table)

Journal Citation Reports ™ 13-23 © 2024 Clarivate

Citing Half-life
6.8 years
The Citing Half-Life is the median age of items in other publications cited by this journal in the JCR
year.

TOTAL NUMBER OF CITES NON-SELF CITATIONS SELF CITATIONS

5,056 5,002 54

# OF CITES FROM CUMULATIVE # OF CITED

2023 % SOURCES

5,056 citations 100.00% 2,483 sources

160 citations 3.16% 128 sources
360 citations 10.28% 250 sources
539 citations 20.95% 365 sources
504 citations 30.91% 384 sources
370 citations 38.23% 312 sources
349 citations 45.13% 279 sources
307 citations 51.21% 261 sources
260 citations 56.35% 232 sources
227 citations 60.84% 195 sources
222 citations 65.23% 196 sources
Previous years:
1,758 citations

Journal Citation Reports ™ 14-23 © 2024 Clarivate

Cited titles in all years
PHARMACIA
SOURCE NAME COUNT

All Others 1,693

1 MOLECULES 61

2 PHARMACIA 54

3 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 41

4 International Journal of Pharmaceutics 40

5 JOURNAL OF ETHNOPHARMACOLOGY 40

6 PLoS One 39

7 NEW ENGLAND JOURNAL OF MEDICINE 31

8 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 29

9 LANCET 29

10 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 26

11 Pharmaceutics 24

12 DIABETES CARE 22

13 Scientific Reports 22

14 BIOMEDICINE & PHARMACOTHERAPY 21

15 Food Chemistry 21

16 Frontiers in Pharmacology 21

17 JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 20

18 Nutrients 20

19 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 18

20 BIOORGANIC & MEDICINAL CHEMISTRY 16

Showing 1 - 20 rows of 675 total (use export in the relevant section to download the full table)

Journal Citation Reports ™ 15-23 © 2024 Clarivate

Journal Citation Relationships
Cited Data
Top 20 journals citing PHARMACIA by number of citations

Journal Citation Reports ™ 16-23 © 2024 Clarivate

Citing Data
Top 20 journals cited by PHARMACIA by number of citations

Journal Citation Reports ™ 17-23 © 2024 Clarivate

Content metrics
Source data
This tile shows the breakdown of document types published by the journal. Citable Items are Articles
and Reviews. For the purposes of calculating JIF, a JCR year considers the publications of that
journal in the two prior years. Learn more

134 total citable items

ARTICLES REVIEWS COMBINED (C) OTHER PERCENTAGE

DOCUMENT
TYPES (O)

NUMBER IN JCR 104 30 134 0 100%

YEAR 2023 (A)

NUMBER OF 3,358 1,698 5,056 0 100%

REFERENCES (B)

RATIO (B/A) 32.3 56.6 37.7 N/A

Average JIF Percentile

The Average Journal Impact Factor Percentile takes the sum of the JIF Percentile rank for each
category under consideration, then calculates the average of those values. Learn more

ALL CATEGORIES AVERAGE PHARMACOLOGY & PHARMACY

16.5 16.5

Journal Citation Reports ™ 18-23 © 2024 Clarivate

Contributions by Organizations
Organizations that have contributed the most papers to the journal in the most recent three-year
period. Learn more

RANK ORGANIZATION COUNT

1 MEDICAL UNIVERSITY SOFIA 64

2 I. HORBACHEVSKY TERNOPIL STATE 37

MEDICAL UNIVERSITY

3 UNIVERSITY OF NORTH SUMATRA 21

4 MEDICAL UNIVERSITY PLEVEN 20

- NATIONAL UNIVERSITY OF PHARMACY 20

6 MINISTRY OF EDUCATION & SCIENCE 18

OF UKRAINE

7 MEDICAL UNIVERSITY PLOVDIV 17

8 MIDDLE EAST UNIVERSITY 15

Showing 1 - 8 rows of 315 total (use export in the relevant section to download the full table)

Contributions by country/region
Countries or Regions that have contributed the most papers to the journal in the most recent three-
year period. Learn more

RANK COUNTRY/REGION COUNT

1 Bulgaria 94

2 Ukraine 82

3 Indonesia 80

4 Jordan 43

5 Iraq 35

6 Saudi Arabia 11

7 India 10

8 Peru 8

Showing 1 - 8 rows of 47 total (use export in the relevant section to download the full table)

Journal Citation Reports ™ 19-23 © 2024 Clarivate

Additional metrics
Eigenfactor score
0.00034
The Eigenfactor Score is a reflection of the density of the network of citations around the journal
using 5 years of cited content as cited by the Current Year. It considers both the number of citations
and the source of those citations, so that highly cited sources will influence the network more than
less cited sources. The Eigenfactor calculation does not include journal self-citations. Learn more

Normalized Eigenfactor
0.07593
The Normalized Eigenfactor Score is the Eigenfactor score normalized, by rescaling the total number
of journals in the JCR each year, so that the average journal has a score of 1. Journals can then be
compared and influence measured by their score relative to 1. Learn more

Journal Citation Reports ™ 20-23 © 2024 Clarivate

Article influence score
0.111
The Article Influence Score normalizes the Eigenfactor Score according to the cumulative size of the
cited journal across the prior five years. The mean Article Influence Score for each article is 1.00. A
score greater than 1.00 indicates that each article in the journal has above-average influence. Learn
more

Journal Citation Reports ™ 21-23 © 2024 Clarivate

5 year Impact Factor
1.0
The 5-year Impact Factor is the average number of times articles from the journal published in the
past five years have been cited in the JCR year. It is calculated by dividing the number of citations in
the JCR year by the total number of articles published in the five previous years.

5 year Impact Factor calculation

Citations in 2023 to items published in [2018-2022]

(380) 380
= = 1.0
Number of citable items in [2018-2022] (376) 376

Journal Citation Reports ™ 22-23 © 2024 Clarivate

Immediacy Index
0.2
The Immediacy Index is the count of citations in the current year to the journal that reference content
in this same year. Journals that have a consistently high Immediacy Index attract citations rapidly.
Learn more

Immediacy Index calculation

Cites in 2023 to items published in [2023]

23
= = 0.2
Number of items published in [2023] 134

Journal Citation Reports ™ 23-23 © 2024 Clarivate